In 2021, the global brain modalities and software market was valued at $13,343.3 million, which is set to reach $23,195.6 million by 2030, at a CAGR of 5.2% during 2021–2030. The growing patient emphasis on early and effective disease diagnosis, advancing demand for non-invasive and safer medical imaging, and surging prevalence of neurological disorders are the key factors that drive the market.
Because traditional methods combined with AI software produce faster and more-reliable results, they are gaining favor. However, although software solutions provide value to standalone imaging modalities, in terms of numerical evaluations, diagnostic accuracy, and precision, software adoption in the LATAM and MEA regions has been slow, which will impel brain modalities and software market players to aggressively market their offerings here.
Key Findings of Brain Modalities and Software Market Report
• APAC is a rapidly growing brain modalities and software market, with a CAGR of roughly 7% predicted over the projection period. The increasing healthcare spending, existence of a large number of market participants, expanding awareness of early illness diagnosis, and rising frequency of brain disorders are driving the demand for radiological equipment and software.
• As the number of persons affected by non-communicable neurological illnesses grows, so will the amount of money spent on treatment. Governments will need to confront a rise in the demand for neurological condition diagnosis, rehabilitation, treatment, and support services, as the population increases and ages.
• Hence, Hyperfine Inc. announced its entry into the Canadian market in December 2021 with Health Canada issuing a license for its portable MRI device, Swoop. The license also covers the recently FDA-approved deep learning-based enhanced reconstructive software.
Browse detailed report on Brain Modalities and Software Market Size and Demand Forecast Report
There are many brain modalities and software market players, such as Mint Labs Inc., IXICO plc, Aspect Imaging Ltd., A.I. Analysis Inc., Imaging Biometrics LLC, Fujifilm Holdings Corporation, Vuno Co. Ltd., Siemens Healthineers AG, Koninklijke Philips N.V., Canon Inc., and General Electric Company. They are engaging in a range of activities to remain competitive and augment their revenue.
For instance, Nano-X Imaging Ltd. completed its merger with Zebra Medical Vision Ltd., a deep learning medical imaging analytics business, in November 2021. USARAD Holdings Inc., a supplier of teleradiology services, and MDWEB LLC, a decentralized marketplace linking imaging providers with radiologists, were also reported as successful strategic acquisitions.
This study covers
• Major factors driving the market and their impact during the short, medium, and long terms
• Market restraints and their impact during the short, medium, and long terms
• Recent trends and evolving opportunities for the market participants
• Historical and the present size of the market segments and understand their comparative future potential
• Potential of on-demand logistics services, so the market players make informed decisions on the sales of their offerings
• Competitive scenario of various market segments across key countries in several regions for uncovering market opportunities for the stakeholders
• Major players operating in the market and their service offerings